Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Gall Bladder Cancer

Clinical Trial at: Woodlands Medical Specialists - Pensacola

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: Gall Bladder Cancer
USOR Number: 18264

  • Practice Details

4724 N. Davis Hwy
Pensacola, FL 32503
P: (850) 696-4000

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Texas Oncology - Plano

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: Gall Bladder Cancer
USOR Number: 18264

  • Practice Details

3705 West 15th Street
Plano, TX 75075
P: (972) 867-3577

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Texas Oncology - Plano

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: Gall Bladder Cancer
USOR Number: 18264

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, TX 75093
P: (972) 596-7801

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Compass Oncology - Portland

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: Gall Bladder Cancer
USOR Number: 18264

  • Practice Details

265 North Broadway
Portland, OR 97227
P: (503) 280-1223

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Compass Oncology - Portland

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: Gall Bladder Cancer
USOR Number: 18264

  • Practice Details

5050 NE Hoyt St, Suite 256
Portland, OR 97213
P: (503) 239-7767

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Southern Cancer Center - Mobile

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: Gall Bladder Cancer
USOR Number: 18264

  • Practice Details

6701 Airport Blvd, Building B, Terrace Level
Mobile, AL 36608
P: (888) 625-6896

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Southern Cancer Center - Mobile

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: Gall Bladder Cancer
USOR Number: 18264

  • Practice Details

3719 Dauphin St., 5th Floor
Mobile, AL 36608
P: (888) 625-6896

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Texas Oncology - New Braunfels

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: Gall Bladder Cancer
USOR Number: 18264

  • Practice Details

1448 East Common St
New Braunfels, TX 78130
P: (830) 643-1762

More Details View Practice Page
1 … 3 4 5 6 7 … 15

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.